Takeda's second bet on DARTs.
D000906:Antibodies / Q000276:immunology / Q000627:therapeutic use*; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000276:immunology; D051925:CD79 Antigens / Q000037:antagonists & inhibitors / Q000276:immunology; D006801:Humans; D058990:Molecular Targeted Therapy; D017452:Receptors, IgG / Q000037:antagonists & inhibitors
D000906:Antibodies; D051925:CD79 Antigens; C080571:Fc gamma receptor IIB; D017452:Receptors, IgG